Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Accumulated Expenses (2016 - 2025)

CV Sciences (CVSI) has disclosed Accumulated Expenses for 13 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 161.49% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, up 161.49% year-over-year, with the annual reading at $1.4 million for FY2025, 161.49% up from the prior year.
  • Accumulated Expenses hit $1.4 million in Q4 2025 for CV Sciences, roughly flat from $1.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $10.9 million in Q4 2021 to a low of $500000.0 in Q1 2023.
  • Historically, Accumulated Expenses has averaged $5.0 million across 5 years, with a median of $3.5 million in 2024.
  • Biggest five-year swings in Accumulated Expenses: plummeted 95.13% in 2023 and later soared 162.64% in 2025.
  • Year by year, Accumulated Expenses stood at $10.9 million in 2021, then plummeted by 38.62% to $6.7 million in 2022, then plummeted by 92.21% to $522000.0 in 2023, then changed by 0.0% to $522000.0 in 2024, then soared by 161.49% to $1.4 million in 2025.
  • Business Quant data shows Accumulated Expenses for CVSI at $1.4 million in Q4 2025, $1.4 million in Q3 2025, and $1.4 million in Q2 2025.